Cargando…
Expression of pancreatic secretory trypsin inhibitor (PSTI) in colorectal cancer.
We examined the expression of pancreatic secretory trypsin inhibitor (PSTI) in colorectal cancer by immunohistochemical staining using an anti-PSTI antiserum, an in situ hybridisation technique utilising sulphonated PSTI cDNA probe, and a Northern blot hybridisation method, using a 32P-labelled PSTI...
Autores principales: | Higashiyama, M., Monden, T., Tomita, N., Murotani, M., Kawasaki, Y., Morimoto, H., Murata, A., Shimano, T., Ogawa, M., Mori, T. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1990
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971550/ https://www.ncbi.nlm.nih.gov/pubmed/2257226 |
Ejemplares similares
-
Identification and characterization of receptors specific for human pancreatic secretory trypsin inhibitor
Publicado: (1990) -
Perforin expression in lymphocytes infiltrated to human colorectal cancer.
por: Nakanishi, H., et al.
Publicado: (1991) -
Pancreatic secretory trypsin inhibitor reduces multi-organ injury caused by gut ischemia/reperfusion in mice
por: Playford, Raymond J., et al.
Publicado: (2020) -
Evaluation of the Pharmacokinetics of the Pancreastatin Inhibitor PSTi8 Peptide in Rats: Integration of In Vitro and In Vivo Findings
por: Valicherla, Guru R., et al.
Publicado: (2022) -
Combination of Pancreastatin inhibitor PSTi8 with metformin inhibits Fetuin-A in type 2 diabetic mice
por: Singh, Pragati, et al.
Publicado: (2020)